Document is current
Any future updates will be listed below
-
Authors
Mercer-Smith, Alison R.
Findlay, Ingrid A.
Bomba, Hunter N.
Hingtgen, Shawn D. https://orcid.org/0000-0003-4355-2377
-
Funding
Funding for this research was provided by:
Eshelman Institute for Innovation, University of North Carolina at Chapel Hill (N/A)
National Cancer Institute (F30CA243270)
- License Information
-
More Information
Article History
Accepted: 24 May 2021
First Online: 17 June 2021
Declarations
:
: S.D.H has an ownership interest in Falcon Therapeutics, Inc., which has licensed aspects of human induced neural stem cell technology from the University of North Carolina at Chapel Hill. A.R.M.S., I.A.F., and H.N.B. have no conflicts to disclose.
